Oral biopharmaceutics tools – Time for a new initiative – An introduction to the IMI project OrBiTo
Year: 2013
Type: review
Authors: H. Lennernäs, L. Aarons, P. Augustijns, S. Beato, M. Bolger, K. Box, M. Brewster, J. Butler, J. Dressman, R. Holm, K. Julia Frank, R. Kendall, P. Langguth, J. Sydor, A. Lindahl, M. McAllister, U. Muenster, A. Müllertz, K. Ojala, X. Pepin, C. Reppas, A. Rostami-Hodjegan, M. Verwei, W. Weitschies, C. Wilson, C. Karlsson, B. Abrahamsson
Institutions: Uppsala University, University of Manchester, KU Leuven, Novartis (Switzerland), Simulations Plus (United States), GlaxoSmithKline Research & Development Limited (United Kingdom), Goethe University Frankfurt, Lundbeck (Denmark), Boehringer Ingelheim (Germany), Merck Serono Ltd. (United Kingdom), Johannes Gutenberg University Mainz, AbbVie (Germany), Medical Products Agency, Pfizer (United Kingdom), Bayer (Germany), University of Copenhagen, Orion Corporation (Finland), Sanofi (France), National and Kapodistrian University of Athens, Netherlands Organisation for Applied Scientific Research, Universität Greifswald, University of Strathclyde, AstraZeneca (Sweden)
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2028811150